We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
Cap. Flow
-$1.96B
Cap. Flow %
-4.91%
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$171M
2
ST icon
Sensata Technologies
ST
+$145M
3
BMY icon
Bristol-Myers Squibb
BMY
+$133M
4
AMZN icon
Amazon
AMZN
+$67.2M
5
ABBV icon
AbbVie
ABBV
+$65.5M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$164M
2
ROST icon
Ross Stores
ROST
+$110M
3
BAC icon
Bank of America
BAC
+$94.4M
4
FCX icon
Freeport-McMoran
FCX
+$92.4M
5
FIVE icon
Five Below
FIVE
+$89.9M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.47%
3 Consumer Discretionary 12.58%
4 Financials 11.29%
5 Communication Services 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
826
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-550,000
Closed -$26.4M
DMS
827
DELISTED
Digital Media Solutions, Inc.
DMS
-9,300
Closed -$1.45M
STSA
828
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-200,000
Closed -$5.75M
AUY
829
DELISTED
Yamana Gold, Inc.
AUY
-1,000,000
Closed -$5.46M
IAA
830
DELISTED
IAA, Inc. Common Stock
IAA
-300,590
Closed -$11.6M
LOGC
831
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
-800,000
Closed -$6.77M
TMX
832
DELISTED
Terminix Global Holdings, Inc.
TMX
-373,499
Closed -$13.3M
GCP
833
DELISTED
GCP Applied Technologies Inc.
GCP
-385,921
Closed -$7.17M
SAFM
834
DELISTED
Sanderson Farms Inc
SAFM
-100,706
Closed -$11.7M
ARNA
835
DELISTED
Arena Pharmaceuticals Inc
ARNA
-190,000
Closed -$12M
ATH
836
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
-250,000
Closed -$7.8M
DRNA
837
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-200,000
Closed -$5.08M
ARYBU
838
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
-300,000
Closed -$3.48M
SHLL.WS
839
DELISTED
Tortoise Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
SHLL.WS
-175,000
Closed -$1.89M
PRNB
840
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
-819,160
Closed -$49M
TMUSR
841
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
-470,134
Closed -$79K
ARYAW
842
DELISTED
ARYA Sciences Acquisiton Corp. Warrant
ARYAW
-625,000
Closed -$3.38M
AAWW
843
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-84,247
Closed -$3.63M
SBNY
844
DELISTED
Signature Bank
SBNY
-35,000
Closed -$3.74M
GRA
845
DELISTED
W.R. Grace & Co.
GRA
-914,525
Closed -$46.5M

Similar funds

Adage Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.

  • Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
  • Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
  • Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
  • Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
  • Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
  • Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
  • Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.

Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.